Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto Rico
BASKING RIDGE, NJ, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata, will deliver a company presentation at the upcoming Sequire Investor Summit being held January 23-25, 2024, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico.
- BASKING RIDGE, NJ, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata, will deliver a company presentation at the upcoming Sequire Investor Summit being held January 23-25, 2024, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico.
- Dr. Mazzo’s presentation will be held on Wednesday, January 24, 2024, at 10:00am Atlantic Standard Time.
- For more information about the Sequire Investor Summit, including registration details, please visit the official event website at https://puertorico.srax.com/ .